Piper Sandler Lowers Illumina (NASDAQ:ILMN) Price Target to $185.00
Illumina (NASDAQ:ILMN – Get Free Report) had its price objective reduced by analysts at Piper Sandler from $190.00 to $185.00 in a report released on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the life sciences company’s stock. Piper Sandler’s price target suggests a potential upside of 121.24% from the stock’s previous close. […]
Illumina (NASDAQ:ILMN – Get Free Report) had its price objective reduced by analysts at Piper Sandler from $190.00 to $185.00 in a report released on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the life sciences company’s stock. Piper Sandler’s price target suggests a potential upside of 121.24% from the stock’s previous close. […]
